H.R. 4385 · 115th Congress
Responsibility in Drug Advertising Act of 2017
- Stage
- In committee
- Sponsor
- Rosa DeLauro
- Introduced
- 2017-11-14
- Latest action
- 2017-11-17 · Referred to the Subcommittee on Health.
Summary
Responsibility in Drug Advertising Act of 2017
This bill amends the Federal Food, Drug, and Cosmetic Act to prohibit direct-to-consumer advertising of a drug in the first three years after the drug's approval. The Food and Drug Administration may: (1) waive the third year of this prohibition for a drug if direct-to-consumer advertising of the drug would have an affirmative value to public health, or (2) extend the prohibition if the drug has significant adverse health effects.